Cigna Investments’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-5,610
Closed -$249K 745
2018
Q2
$249K Sell
5,610
-1,026
-15% -$51K 0.02% 637
2018
Q1
$323K Sell
6,636
-328
-5% -$16.4K 0.02% 624
2017
Q4
$348K Sell
6,964
-100
-1% -$5.24K 0.02% 638
2017
Q3
$358K Sell
7,064
-1
-0% -$47 0.02% 605
2017
Q2
$268K Sell
7,065
-393
-5% -$15.5K 0.02% 666
2017
Q1
$287K Buy
+7,458
New +$224K 0.02% 607

Other funds holding CC

Cigna Investments's CC Position: Q3 2018 in Review

Cigna Investments sold out of Chemours (CC) in Q3 2018, closing a stake of 5,610 shares — an estimated $249K sold.

Cigna Investments first reported a position in CC in Q1 2017 and held it in 6 quarters. The position peaked at $358K in Q3 2017. 551 funds tracked by Wall St. Rank hold CC as of Q3 2018.

  • Cigna Investments reported no remaining Chemours position as of Q3 2018 after selling out during the quarter.
  • Cigna Investments sold 5,610 Chemours shares in Q3 2018, an estimated $249K.
  • Cigna Investments first reported a position in Chemours in Q1 2017 and held it in 6 quarters.
  • Cigna Investments's Chemours position peaked at $358K in Q3 2017.
  • 551 funds tracked by Wall St. Rank held Chemours as of Q3 2018.

Based on Cigna Investments's 13F filing for Q3 2018, filed 13 Nov 2018.